Klaus Borner
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 20
- Antibiotics Pharmacokinetics and Efficacy 20
- Epidemiology 12
- Pneumonia and Respiratory Infections 8
- Herpesvirus Infections and Treatments 4
- Co-authors
- H. Lode (13 shared papers)P. Koeppe (6 shared papers)Annette Lubasch (1 shared paper)Oliver Liesenfeld (4 shared papers)Rainer Müller (4 shared papers)Helmut Hahn (2 shared papers)Rudolf Fitzner (3 shared papers)Oliver Kayser (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)Chemotherapy (3 papers)Clinical Microbiology and Infection (2 papers)The American Journal of Medicine (2 papers)International Journal of Antimicrobial Agents (2 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Klaus Borner
33 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 112
- Molecular Medicine 121
- Pharmacology 392
- Pharmaceutical Science 107
- Parasitology 111
- Applied Microbiology and Biotechnology 33
Countries citing papers authored by Klaus Borner
This map shows the geographic impact of Klaus Borner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Borner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Borner more than expected).
Fields of papers citing papers by Klaus Borner
This network shows the impact of papers produced by Klaus Borner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Borner. The network helps show where Klaus Borner may publish in the future.
Co-authors
The 25 scholars most cited alongside Klaus Borner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 207 | |
| 2 | 2000 | 153 | |
| 3 | 2001 | 99 | |
| 4 | 1989 | 79 | |
| 5 | 2001 | 70 | |
| 6 | 2007 | 69 | |
| 7 | 2004 | 57 | |
| 8 | 1985 | 50 | |
| 9 | 2010 | 49 | |
| 10 | 1992 | 33 | |
| 11 | 2002 | 31 | |
| 12 | 2005 | 30 | |
| 13 | 2009 | 28 | |
| 14 | 1998 | 28 | |
| 15 | 2005 | 16 | |
| 16 | 1970 | 16 | |
| 17 | 1999 | 15 | |
| 18 | 1987 | 15 | |
| 19 | 1999 | 12 | |
| 20 | 1996 | 12 |
About Klaus Borner
Klaus Borner is a scholar working on Pharmacology, Epidemiology, Molecular Medicine, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Pneumonia and Respiratory Infections (8 papers), Antibiotic Resistance in Bacteria (6 papers), Analytical Methods in Pharmaceuticals (4 papers), Epilepsy research and treatment (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Toxoplasma gondii Research Studies (4 papers) and Herpesvirus Infections and Treatments (4 papers). The work is most often cited by research in Molecular Medicine (121 citations), Pharmacology (392 citations), Pharmaceutical Science (107 citations), Parasitology (111 citations) and Applied Microbiology and Biotechnology (33 citations). Klaus Borner has collaborated with scholars based in Germany, United States and France. Frequent co-authors include H. Lode, P. Koeppe, Annette Lubasch, Oliver Liesenfeld, Rainer Müller, Helmut Hahn, Rudolf Fitzner, Oliver Kayser, Ivica Grgic and H. Peter Reusch. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Chemotherapy, Clinical Microbiology and Infection, The American Journal of Medicine and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.